Recombinant Protein Vaccine Market Report

Global Recombinant Protein Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：148
  • REPORT CODE：GMM848127
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant Protein Vaccine market report explains the definition, types, applications, major countries, and major players of the Recombinant Protein Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Medicago

    • GSK

    • Zoties

    • Merck

    • Indian Immunologicals

    • Plumbline Life Sciences

    • Elanco

    • Novavax

    • Boehringer-Ingelheim

    • Sanofi

    By Type:

    • Bacterial Cells Culture

    • Mammalian Cells Culture

    By End-User:

    • Human

    • Animal

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Recombinant Protein Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Recombinant Protein Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Recombinant Protein Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Recombinant Protein Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Recombinant Protein Vaccine Market- Recent Developments

    • 6.1 Recombinant Protein Vaccine Market News and Developments

    • 6.2 Recombinant Protein Vaccine Market Deals Landscape

    7 Recombinant Protein Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Recombinant Protein Vaccine Key Raw Materials

    • 7.2 Recombinant Protein Vaccine Price Trend of Key Raw Materials

    • 7.3 Recombinant Protein Vaccine Key Suppliers of Raw Materials

    • 7.4 Recombinant Protein Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Recombinant Protein Vaccine Cost Structure Analysis

      • 7.5.1 Recombinant Protein Vaccine Raw Materials Analysis

      • 7.5.2 Recombinant Protein Vaccine Labor Cost Analysis

      • 7.5.3 Recombinant Protein Vaccine Manufacturing Expenses Analysis

    8 Global Recombinant Protein Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Recombinant Protein Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Recombinant Protein Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Recombinant Protein Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Protein Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Bacterial Cells Culture Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Mammalian Cells Culture Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Protein Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Human Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Animal Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Recombinant Protein Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.2 UK Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.5 France Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.3 India Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Recombinant Protein Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Recombinant Protein Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Recombinant Protein Vaccine Consumption (2017-2022)

    11 Global Recombinant Protein Vaccine Competitive Analysis

    • 11.1 Medicago

      • 11.1.1 Medicago Company Details

      • 11.1.2 Medicago Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Medicago Recombinant Protein Vaccine Main Business and Markets Served

      • 11.1.4 Medicago Recombinant Protein Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Recombinant Protein Vaccine Main Business and Markets Served

      • 11.2.4 GSK Recombinant Protein Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Zoties

      • 11.3.1 Zoties Company Details

      • 11.3.2 Zoties Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Zoties Recombinant Protein Vaccine Main Business and Markets Served

      • 11.3.4 Zoties Recombinant Protein Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck

      • 11.4.1 Merck Company Details

      • 11.4.2 Merck Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Recombinant Protein Vaccine Main Business and Markets Served

      • 11.4.4 Merck Recombinant Protein Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Indian Immunologicals

      • 11.5.1 Indian Immunologicals Company Details

      • 11.5.2 Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Indian Immunologicals Recombinant Protein Vaccine Main Business and Markets Served

      • 11.5.4 Indian Immunologicals Recombinant Protein Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Plumbline Life Sciences

      • 11.6.1 Plumbline Life Sciences Company Details

      • 11.6.2 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Plumbline Life Sciences Recombinant Protein Vaccine Main Business and Markets Served

      • 11.6.4 Plumbline Life Sciences Recombinant Protein Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Elanco

      • 11.7.1 Elanco Company Details

      • 11.7.2 Elanco Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Elanco Recombinant Protein Vaccine Main Business and Markets Served

      • 11.7.4 Elanco Recombinant Protein Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Novavax

      • 11.8.1 Novavax Company Details

      • 11.8.2 Novavax Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Novavax Recombinant Protein Vaccine Main Business and Markets Served

      • 11.8.4 Novavax Recombinant Protein Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Boehringer-Ingelheim

      • 11.9.1 Boehringer-Ingelheim Company Details

      • 11.9.2 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Boehringer-Ingelheim Recombinant Protein Vaccine Main Business and Markets Served

      • 11.9.4 Boehringer-Ingelheim Recombinant Protein Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Sanofi

      • 11.10.1 Sanofi Company Details

      • 11.10.2 Sanofi Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Sanofi Recombinant Protein Vaccine Main Business and Markets Served

      • 11.10.4 Sanofi Recombinant Protein Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Recombinant Protein Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Bacterial Cells Culture Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Mammalian Cells Culture Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Human Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Animal Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Recombinant Protein Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Recombinant Protein Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Recombinant Protein Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Recombinant Protein Vaccine

    • Figure of Recombinant Protein Vaccine Picture

    • Table Global Recombinant Protein Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Recombinant Protein Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Bacterial Cells Culture Consumption and Growth Rate (2017-2022)

    • Figure Global Mammalian Cells Culture Consumption and Growth Rate (2017-2022)

    • Figure Global Human Consumption and Growth Rate (2017-2022)

    • Figure Global Animal Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Table North America Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure United States Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure Germany Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure China Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Recombinant Protein Vaccine Consumption by Country (2017-2022)

    • Figure Australia Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)

    • Table Medicago Company Details

    • Table Medicago Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicago Recombinant Protein Vaccine Main Business and Markets Served

    • Table Medicago Recombinant Protein Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Recombinant Protein Vaccine Main Business and Markets Served

    • Table GSK Recombinant Protein Vaccine Product Portfolio

    • Table Zoties Company Details

    • Table Zoties Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zoties Recombinant Protein Vaccine Main Business and Markets Served

    • Table Zoties Recombinant Protein Vaccine Product Portfolio

    • Table Merck Company Details

    • Table Merck Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Recombinant Protein Vaccine Main Business and Markets Served

    • Table Merck Recombinant Protein Vaccine Product Portfolio

    • Table Indian Immunologicals Company Details

    • Table Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indian Immunologicals Recombinant Protein Vaccine Main Business and Markets Served

    • Table Indian Immunologicals Recombinant Protein Vaccine Product Portfolio

    • Table Plumbline Life Sciences Company Details

    • Table Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Plumbline Life Sciences Recombinant Protein Vaccine Main Business and Markets Served

    • Table Plumbline Life Sciences Recombinant Protein Vaccine Product Portfolio

    • Table Elanco Company Details

    • Table Elanco Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elanco Recombinant Protein Vaccine Main Business and Markets Served

    • Table Elanco Recombinant Protein Vaccine Product Portfolio

    • Table Novavax Company Details

    • Table Novavax Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax Recombinant Protein Vaccine Main Business and Markets Served

    • Table Novavax Recombinant Protein Vaccine Product Portfolio

    • Table Boehringer-Ingelheim Company Details

    • Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer-Ingelheim Recombinant Protein Vaccine Main Business and Markets Served

    • Table Boehringer-Ingelheim Recombinant Protein Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Recombinant Protein Vaccine Main Business and Markets Served

    • Table Sanofi Recombinant Protein Vaccine Product Portfolio

    • Figure Global Bacterial Cells Culture Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mammalian Cells Culture Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Animal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US